Cormorant Asset Management, LP Arcturus Therapeutics Holdings Inc. Transaction History

Cormorant Asset Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$34.61 - $123.66 $24.2 Million - $86.6 Million	-700,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$37.49 - $63.19 $3.75 Million - $6.32 Million	-100,000 Reduced 12.5%	700,000 $30 Million
Q2 2020 Aug 14, 2020	BUY	$12.66 - $58.27 $6.81 Million - $31.3 Million	537,963 Added 205.3%	800,000 $37.4 Million
Q1 2020 May 15, 2020	BUY	$9.31 - $18.26 $2.44 Million - $4.78 Million	262,037 New	262,037 $3.56 Million

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $450M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.